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Cellular free Zn
2+
4changes, including those in the sarco(endo)plasmic reticulum [S(E)R], are 
primarily coordinated by Zn
2+
 transporters. The role of these in the heart is not well 
established. To investigate the hypotheses that ZIP7 and ZnT7 transport Zn
2+ 
in opposing 
directions across the S(E)R membrane in cardiomyocytes and that changes in the expression 
of these transporters play an important role in development of ER4stress during 
hyperglycemia. The subcellular localization of ZIP7 and ZnT7 was determined in rat 
cardiomyocytes by immunofluorescence imaging and confirmed by Western (immune4) blot 
analysis of isolated S(E)R preparations. ZIP7 mRNA and protein levels were increased in 
ventricular cardiomyocytes from diabetic rats or high glucose4treated H9c2 cells whilst ZnT7 
expression was lowered under these conditions. The above changes were associated with ER 
stress. Assessed using recombinant4targeted eCALWY Zn
2+
 probes, hyperglycemia induced a 
marked redistribution of cellular free Zn
2+
,
 
increasing cytosolic free Zn
2+ 
and lowering free 
Zn
2+
 in the S(E)R.  Silencing of ZIP7 prevented these changes. High glucose also increased 
expression of protein kinase 2 consistent with a role of the latter kinase in controlling ZIP7 
activity. Opposing changes in the expression of ZIP7 and ZnT7 are likely to contribute to a 
redistribution of intracardiomyocyte Zn
2+
 in hyperglycemia and to diabetes4induced cardiac 
dysfunction. These data provide novel and important insights into how cellular free Zn
2+
 re4 
distribution, resulting from altered ZIP7 and ZnT7 activity in the hyperglycemic heart, can 
contribute to cardiac dysfunction in diabetes. In summary, these findings may provide new 
targets against diabetes4induced cardiac dysfunction for the new therapeutic strategies. 
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Diabetes mellitus (both Type 1 and Type 2) is an important risk factor for the development of 
cardiovascular complications, which is due, in large part, to defective cytosolic Ca
2+
 signaling 
(143)
 
. Previously, we have shown that Zn
2+
 release during cardiac cycle (4) results mostly in a 
cytosolic free Zn
2+ 
increase,
 
further triggering higher production of pro4oxidant species and 
leading to oxidative damage (5). Conversely, it has also been shown that either acute or 
chronic oxidant exposure induces marked increases in cytosolic free Zn
2+ 
in cardiomyocytes
(6) while either acute or chronic hyperglycemia causes oxidative stress and increased levels of
cytosolic free  Zn
2+
, underling electrical and mechanical dysfunction in the heart (7; 8). 
Similar to Ca
2+
, Zn
2+
 is essential for several cellular functions in mammalian heart, including 
cell growth and differentiation (9), serving up as an important secondary messenger (10).  
Zn
2+
 deficiency in mammals (11) can increase the risk of development of many 
complications. Conversely, excess Zn
2+
 can be detrimental to cellular health, particularly that 
of cardiomyocytes (4; 6; 7; 9). Free cytosolic Zn
2+ 
has an important role in excitation4 
contraction coupling in cardiomyocytes by shaping Ca
2+ 
dynamics (4; 5; 12). The free 
cytoplasmic Zn
2+
 concentration in cardiomyocytes is calculated to be less than 1 nM under 
physiological conditions, while it is ~54fold higher in sarco(endo)plasmic reticulum [S(E)R] 
by using Frster resonance energy transfer (FRET)4based recombinant4targeted Zn
2+
 probes 
(13). Elevated cytosolic free Zn
2+
 appears to contribute to deleterious changes in many 
signaling pathways, similar to those observed in hyperglycemia4challenged cardiac cells (447; 
14). 
Cellular Zn
2+ 
fluxes are achieved and controlled by families of Zn
2+
4transporters (ZnT) and
importers (ZIP) (15; 16). The cellular distributions and functions of these transporters are not 
yet well clarified in mammalian cardiomyocytes. As reviewed recently (16), the ZIP family 
increases the cytosolic free Zn
2+
 level by promoting extracellular uptake or release of these
3 
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ions from subcellular organelles, whereas ZnT family members function as counter regulators 
via efflux of cytosolic Zn
2+ 
(16). Many proteins use Zn
2+
 as an important cofactor and the 
Zn
2+
4selective ion channel ZIP7 has important role for releasing Zn
2+ 
from the ER and Zn
2+
4 
associated induction of unfolded protein response in yeast (17). Similarly, ZIP7 is believed to 
be localized to the Golgi apparatus in Chinese Hamster Ovary cells, where it allows Zn
2+ 
release from the Golgi lumen into the cytosol (18). ZIP7 facilitates the release of Zn
2+ 
from 
the ER (19) and behaves as a critical component in the sub4cellular re4distribution of Zn
2+ 
in 
other systems
 
(20). Additionally, it has been hypothesized that protein kinase42 (CK2) triggers 
cytosolic Zn
2+
 signaling pathways by phosphorylating ZIP7 (21). Recent studies have also 
highlighted the important contribution of ZIP7 to Zn
2+
 homeostasis in mammalian cells, 
particularly under pathological conditions (22424).  
Of note, the expression profiles of the Zn
2+
 transporters vary markedly and are dependent on 
tissue type and health or disease state as well. Although early and recent studies have shown 
the presence of the weakly expressed Zn
2+
4transporters ZIP7 and ZnT7 in mammalian heart 
(25; 26), their subcellular localizations and functional roles under physiological and 
pathological conditions are not yet known. In that regard, recent studies have suggested that 
either increase or inhibition of either ZIP7 or ZnT7 might contribute to cellular dysfunction, 
including defective insulin4mediated signaling pathways under high glucose (27) or altered 
insulin secretion from the pancreatic β cell (28). Polymorphisms in the genes encoding Zn
2+
4 
transporters play also play important roles in a number of inherited human diseases, including 
diabetes mellitus (29431).  
ER stress is one of the underlying mechanisms of cardiac dysfunction including diabetic 
cardiomyopathy (32435) and there is relationship between if S(E)R function cytosolic free 
Zn
2+
 level in diabetic rat cardiomyocytes (34; 36). In particular, the latter studies identified a 
close association between oxidative stress, cytosolic free Zn
2+ 
increases, ER4stress and cardiac
4 
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dysfunction in diabetes. Other experimental evidence suggests a requirement for Zn
2+ 
for 
proper ER4function, with Zn
2+
 deficiency leading to induction of ER4stress (17; 37). In 
another direction, activation of an ER4stress response has also been observed when Zn
2+
 is 
decreased in the ER via hypoxia or hypoglycemia (17; 38). However, there are no clear data 
as to which Zn
2+
4transporters play roles in controlling cytosolic free Zn
2+ 
increases in 
cardiomyocytes during hyperglycemia.  
It is therefore tempting to hypothesize that the disruption of a Zn
2+
 transporter4Zn
2+
 axis may 
contribute to deleterious changes in cardiomyocytes in diabetes. Here, we provide evidence 
for the existence of a Zn
2+
 transporter system comprising ZIP7 and ZnT7 which are localized 
to the S(E)R and transport Zn
2+ 
in opposing directions. If such a system were perturbed during 
hyperglycemia, depleting S(E)R Zn
2+
, this may in turn lead to ER4stress. In this study, we 
aimed firstly to clarified the subcellular localizations of ZIP7 and ZnT7 in cardiomyocytes 
and then to explore their functional roles on Zn
2+
 homeostasis. Additionally, we tested the 
role of cytosolic free Zn
2+
 re4distribution and the development of ER4stress in hyperglycemic 
conditions, and the role in this of process of CK2. Our results provide evidence of a key role 
for ZIP7 and ZnT7 which are perturbed by hyperglycemia and can contribute to the 
development of cardiac dysfunction via induction of ER4stress in diabetic subjects.  
	*$ 
 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Our study was approved by the local experimental animal ethic committee of Ankara 
University (1154449).  We used 34month4old male Wistar rats and diabetes (mimic of Type 1 
diabetes) was induced by a single injection of streptozotocin (STZ, 50 mg/kg dissolved in 0.1 
M citrate buffer at pH 4.5; intraperitoneal; Sigma4Aldrich), as described previously (3). The 
second group of rats, kept as controls (CON group), were injected with citrate4buffered saline. 
A week after the, blood glucose levels were measured and rats with blood glucose levels at 
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least 34fold higher than the pre4injection levels were used as diabetic group (DM group). 

	   
Left ventricular myocytes were isolated from fresh tissue, as described previously (6). 
Shortly, rats were anaesthetized with sodium pentobarbital (30 mg/kg body weight, 
intraperitoneal), and the hearts were removed and cannulated on a Langendorff apparatus 
leaving perfused retrogradely through the coronary arteries with a Ca
2+
4free solution. Hearts 
were perfused to clean out for 546 minutes, followed by perfusion with the same solution 
containing 1 mg/mL collagenase (Collagenase Type 2, Worthington, USA) for 30435 minutes. 
In every isolation procedure, the percentage of viable cells was more than 80% in either 
group. Only Ca
2+ 
tolerant cells were used incubated in a 1 mmol/L Ca
2+
containing solution.
 
The left ventricle of the embryonic rat heart tissue4derived H9c2 cardiac myoblast cell line 
was purchased from American Type Culture Collection (Manassas, VA). Cells were cultured 
in Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum and 100 
units penicillin4streptomycin at 37°C in a humidified 5% CO2495%. Cells were grown at a 
density of about 10
5
 cells/cm
2
 in DMEM modified by using 5.5 mM glucose instead of high 
glucose and supplemented with 10% fetal calf serum, 50 U/mL penicillin4G and 50 Rg/mL 
streptomycin in a humidified atmosphere of 95% air and 5% CO2. 

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Cytosolic and S(E)R free Zn
2+
 levels ([Zn
2+
]Cyt and [Zn
2+
]ER, respectively) inH9c2 cells were 
measured by using eCALWY sensors (Cyt4eCALWY4 and ER4eCALWY6), delivered with 
plasmids expressing Cyt4eCALWY4 and ER4eCALWY6 and ratiometric measurements are 
performed as described previously (13). Briefly, Images were captured at 433 nm 
6 
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monochromatic excitation wavelength (Polychrome IV, Till photonics) using an Olympus IX4 
70 wide4field microscope with a 40×/1.35NA oil immersion objective and a zyla sCMOS 
camera (Andor Technology) controlled by Micromanager software. Image analysis was 
performed with ImageJ software using a homemade macro and the fluorescence emission 
ratios were derived after subtracting background. The steady4state fluorescence intensity ratio 
citrine/cerulean (R) was measured, then maximum and minimum ratios were determined to 
calculate free Zn
2+
 level by using the following formula: [Zn
2+
]=Kd(Rmax−R)/(R−Rmin). The 
maximum ratio (Rmax) was obtained upon intracellular Zn
2+ 
chelation with 50 RM heavy metal 
chelator N,N,N’,N’4tetrakis(24pyridylmethyl) ethylenediamine (TPEN, Sigma4Aldrich, USA) 
and the minimum ratio (Rmin) was obtain upon Zn
2+
 saturation with 100 RM ZnCl2 in the 
presence of an ionophore pyrithione (Pyr, 5 RM).  
!) -	3       
	  /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
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		
Localization of the endogenous Zn
2+
 transporters, ZIP7 (Thermofisher, PA5421072; 1:50) and 
ZnT7 (Santa Cruz, SC4160946; 1:50) in cardiomyocytes was determined by using anti4ZIP7 
and anti4ZnT7 antibodies, respectively, using confocal microscopy (Zeiss LSM510). S(E)R 
localization was determined by transfection of H9c2 cells with dsRED4ER (red) plasmid for 
24 hours. After fixation and permeabilization of H9c2 cells with 4% paraformaldehyde and 
0.2% Triton4X100, respectively, they were incubated with either the ZIP7 or ZnT7 antibody 
to monitor the localization of ZIP7 and ZnT7 protein in the S(E)R. After overnight incubation 
of the cells, they were further incubated with appropriate secondary antibodies in the presence 
of 5% (w/v) BSA (Alexa Fluor 488 Donkey anti4Rabbit for ZIP7; 1:1000, Alexa Fluor 488 
Donkey anti4Goat for ZnT7; 1:1000). 
The Golgi apparatus was labeled using an Anti4GM130 antibody cis4Golgi Marker (Abcam; 
ab52649; 1:750). After fixation and permeabilization, H9c2 cells were incubated either with 
7 
Page 8 of 40Diabetes
anti4ZIP7, 4ZnT7 or the Golgi marker GM130 antibody to demonstrate the localization of 
ZIP7 and ZnT7 protein in this compartment. Following overnight incubation, cells were 
further incubated with appropriate secondary antibodies (Alexa Fluor 488 Donkey anti4Rabbit 
for ZIP7; 1:1000 and Alexa Fluor 568 Goat anti4Mouse for GM130; 1:1000, Alexa Fluor 488 
Donkey anti4Goat for ZnT7; 1:1000 and Alexa Fluor 647 Rabbit anti4Mouse for GM130; 
1:1000) and were mounted with medium containing DAPI (blue). Images were deconvolved 
and analyzed for colocalization by using Huygens software and processed with ImageJ 
(https://svi.nl/HuygensProfessional). 
 !	"#
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
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Sarco(endo)plasmic reticulum, S(E)R fractionation of small trabeculae isolated from left 
ventricle of rat heart was performed by using an ER isolation kit (Sigma, E0100). Briefly, 
heart tissues were homogenized in isotonic extraction buffer and then centrifuged. The crude 
microsomal fraction was isolated from a post4mitochondrial fraction by using 
ultracentrifugation. For further purification and separation of RER (rough ER) and SER 
(smooth ER) from microsomes, self4generating density gradient procedure was performed 
according to manufacturer’s instructions.  Finally, Western (immuno4) blot analysis was 
carried out using primary antibodies against ZIP7 (Thermofisher, PA5421072) ZnT7 (Santa 
Cruz, SC4160946). To confirm proper isolation of endoplasmic reticulum, SERCA42 (Santa 
Cruz, SC48094) was used as ER marker and 58K Golgi Protein (Abcam, ab427043) was used 
as Golgi marker 
4	4&5		&  . )	  
The H9c2 cells were stably transfected with 4 unique 29mer shRNA constructs in lentiviral 
RFP vector (Origene, SR02938179A, B, C and D) and Non4effective 294mer scrambled 
shRNA cassette in pRFP4CB4shLenti Vector as a control (Origene, TR30033). Following 24 
hours before the transfection, the HEK293T cells were seeded into separate dishes. Every 
8 
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shRNA construct with packaging and enveloping plasmids (psPAX; Addgene 12260 and 
pMD2G; Addgene 12259) were mixed into a solution contained CaCl2 (375 mM) and then 
incubated for 30 minutes at room temperature. Every DNA mixture was added into HBS 
buffer (containing as mM; 12 Dextrose, 50 HEPES, 10 KCl, 280 NaCl, 1.5 Na2HPO4.H2O) as 
a drop wise manner while vortex and every mixture added into separate 15 cm dishes and 
incubated for 12 hours. Viral supernatants were harvested following 24 hours and 48 hours. 
The H9c2 cells were infected with each lentivirus produced from every shRNA construct 
including scrambled sequences at 3 PFU per cell. After infection, cells are incubated with 
medium contains blasticidin (10 µg/mL) for antibiotic selection. Then, the cells were seeded 
and into 6 well plates and harvested for determining the knocked4down efficiency by 
measuring the mRNA expression levels of ZIP7 (Supplementary Table I). For our 
experiments, we used the mixture of 4 ZIP7 gene specific shRNA constructs. 
6( +( 
Total RNAs were prepared from isolated cardiomyocytes and H9c2 cells using an RNA 
Isolation Kit (Macherey–Nagel, 740955.10). Purified total RNA was reverse transcribed using 
ProtoScript First4Strand cDNA Synthesis Kit (New England Biolobs, E6300S). The resulting 
first strand cDNAs were quantified with GoTaq® qPCR Master Mix (Promega, A6001). As a 
housekeeping gene, β4actin () was used and expression results for all transcription factors 
were normalized with respect to β4actin mRNA levels. The amplified fragment size of the 
PCR products of each primer and the specificity of the primers were controlled with NCBI 
and ENSEMBL databases which are publicly available. The primer sequences for β4actin, 
ZIP7 and ZnT7 were listed in a Table given in Supplemental Materials. The fold changes in 
the expression of the genes were analyzed based on the comparative (2
4[[Ct
) method.
1 "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Frozen isolated cardiomyocytes and isolated sarco(endo)plasmic reticulum S(E)R fractions 
were pulverized at liquid nitrogen temperature and then homogenized. Cell lysates and tissues 
homogenates were extracted with NP440 lysis buffer (250 mM NaCl, 1% NP440, and 50 mM 
Tris4HCl; pH 8.0 and 1X PIC). The protein concentrations of supernatants after centrifugation 
(12,000×g, 5 minutes, at 4°C) were measured with the BCA assay kit (Pierce). Equal protein 
amounts were separated on 12% SDS4PAGE Tris4glycine or 4412% Bis4Tris gels (Life 
Technologies). Proteins were transferred to PVDF membranes and blocked with 4% skimmed 
milk solution in PBS4Tween. Membranes were probed overnight with primary antibodies 
diluted in 4% skimmed milk solution in PBS4Tween. The membranes were probed with 
antibodies against GRP78 (Santa Cruz, sc413968; 1:200), Calregulin (Santa Cruz, sc411398; 
1:200), ZIP7 (Santa Cruz, sc483858; 1:200), ZnT7 (Santa Cruz,sc4160946; 1:200), SERCA42 
(Santa Cruz, sc48094, 1:200), 58K Golgi Protein (Abcam, ab427043; 1µg/ml), GAPDH (Santa 
Cruz,sc4365062; 1:1000) and  β4actin (Santa Cruz, sc447778; 1:500) in BSA/PBS/Tween420 
solution.  
Specific bands were visualized with HRP4conjugated compatible secondary antibodies (anti4 
mouse: 1:2000, anti4goat: 1:7500, anti4rabbit: 1:7500) and detected by ImmunoCruz Western 
Blotting Luminol Reagent (Santa Cruz, sc42048).  The density of bands was analyzed using 
ImageJ software. 


	  (
Cells were treated as indicated, lysed in co4immunoprecipitation (co4IP) buffer (50 mM Tris, 
pH 7.4, 100 mM NaCl, 1% Triton4X4100, 10% glycerol, 1 mM EDTA) containing protease 
inhibitors (1 mM PMSF, 1 Rg/mL each of leupeptin, aprotinin and pepstatin) and phosphatase 
inhibitors (10 mM sodium fluoride, 1 mM sodium orthovanadate) for 30 minutes at 4°C with 
gentle shaking. The 600 Rg protein lysates from aliquots (1 mL of lysis buffer) were pre4 
cleared via incubation with 30 RL of protein A/G Sepharose (Sigma, USA) for 1 hour at 4°C. 
10 
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The pre4cleared samples were incubated with the specific primary antibody (anti4CK2α, 10 
Rg/mL; Santa Cruz, SC46480) in lysis buffer for 2 hours at 4°C and then 30 RL of protein A/G 
beads were added. Following these procedures, the samples were incubated for overnight at 
4°C and then the beads were washed five times with lysis buffer at 4°C and then boiled and 
separated by 10% SDS4PAGE. Finally, they were transferred onto a PVDF membrane 
followed by Western blotting analysis. 
* (!   	 
Data are presented as mean ± SEM unless otherwise stated. Differences were determined by 
using Student’s t4test with Bonferroni correction for multiple comparisons as required, using 
GraphPad Prism 6.0. P4values < 0.05 were considered as statistically significant.
 
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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We aimed first to confirm the presence of both ZIP7 and ZnT7 in isolated cardiomyocytes by 
measuring their protein and mRNA levels under both physiological and chronic 
hyperglycemic (such as STZ4induced diabetic rats, DM group) conditions. The protein (right 
part) and mRNA (left part) levels of ZIP7 (at 50 kDa) and ZnT7 (at 42 kDa) measured in 
isolated rat ventricular cardiomyocytes are given in Fig. 1A and B. Both mRNA and protein 
(immunoreactivity) levels of ZIP7 were significantly increased in cardiomyocytes from 
diabetic rats whereas those of ZnT7 were found to be significantly decreased. 
In order to test, a direct high glucose exposure to cardiomyocytes can induce the above 
changes, we incubated the isolated left ventricular cardiomyocytes with high glucose (33 mM) 
for 3 hours and then examined the protein and mRNA levels of both ZIP7 and ZnT7 
comparison to those of mannitol (+23 mM) incubated cardiomyocytes. Their mRNA levels 
are changing as parallel to those of chronic hyperglycemic conditions (Supplementary Fig. 1) 
11 
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while their protein levels are changed about 10% which is not statistically significant (data not 
shown). These differences may be due to not enough period high glucose incubation of the 
cells to induce changes in the protein levels. Of note, we did avoid to usage of longer 
incubation period for freshly isolated cells with high glucose.  
In another set of experiments for further validation, we used high glucose (25 mM) incubated 
(24 hours) H9c2 cells and measured the protein and mRNA levels of ZIP7 and ZnT7. As can 
be seen from Fig. 1C and D, the protein and mRNA levels (Fig. 1C) of ZIP7 increased 
significantly in high glucose incubated H9c2 cells, while the ZnT7 mRNA level (Fig. 1D) is 
markedly (∼75%) decreased with relatively small decrease (∼25%) in its protein level. 
7		 
	 
Since it has been previously shown a marked high phosphorylation level of ZIP7 by using a 
specific antibody developed by one of us (KT) in breast cancer cells (21), in this group of 
examinations, we aimed to examine a possible dependency of ZIP7 phosphorylation to 
hyperglycemia in both diabetic rat cardiomyocytes and high glucose incubated H9c2 cells (25 
mM for 24 or 48 hours) comparison to non4incubated cells by Western blot analysis. As 
shown in Fig. 1 E and F, phospho4ZIP7 level measured at about 50 kDa in chronic 
hyperglycemic cells was about 74fold higher comparison to the controls (A). Furthermore, the 
phospho4ZIP7 level in high glucose incubated H9c2 cells was high comparison to non4 
incubated cells, as a time4dependent manner, such as about 22% high in 244 our incubation 
and % in 484 our incubation (F; left and right, respectively). 
0 -	3  !	"#
	 	
5	
The expression levels of ZIP7 and ZnT7 have previously been reported in mammalian heart 
tissue(25; 26) and both have been proposed to localize to the ER membrane(20; 24; 28) and/or 
perinuclear vesicles associated with the Golgi apparatus(25; 27) in different types of cells. 
12 
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Furthermore, it has been shown recently that endogenously expressed ZIP6 and ZIP7 are co4 
localized predominantly to the ER and regulate cytosolic Zn
2+
 homeostasis in dispersed 
pancreatic islet cells (22).  
Therefore, we postulated first the similar endogenous subcellular localization for ZIP7 and 
ZnT7 as S(E)R in the H9c2 cardiac cells. To examine this postulate, the H9c2 cells were first 
transfacted with ER4resident Discosoma red fluorescent protein (DsRed4ER), then the cells 
were fixed and incubated with polyclonal antibodies to either ZIP7 or ZnT7 protein. DAPI 
was used to stain DNA in the nucleus. To visualize either ZIP7 or ZnT7 localization to the 
S(E)R, the ZIP74specific and the ZnT74specific antibodies and secondary antibodies were 
used. Individual and merged confocal microscopic images are shown in the four panels (Fig. 
2A and B, respectively). The merge visual inspections can be attributed to the presence of the 
majority of ZIP7 and ZnT7 to the S(E)R. For colocalization values (the Pearson coefficient) 
calculated for ZIP7 and S(E)R and ZnT7 and S(E)R by using Huygens programme, are found 
as 0.67± 0.07 and 0.72±0.13, respectively. 
To examine whether ZIP7 and ZnT7 localizes to Golgi apparatus, the H9c2 cells were co4 
incubated with GM130 and ZIP7 or ZnT7 antibodies and appropriate  secondary antibodies. 
DAPI was again used to stain DNA in the nucleus. Individual and merged confocal 
microscopic images are shown in the four panels (Fig. 2C and D). The merge visual 
inspections can be attributed to the presence of minority of either ZIP7 or ZnT7 to the Golgi. 
For colocalization values (the Pearson coefficient) calculated for ZIP7 and Golgi and ZnT7 
and Golgi by using Huygens programme, are found as 0.29±0.02 and 0.51±0.06, respectively. 
DsRED4ER (red) plasmid transfected or non4transfected cells were incubated with only 
secondary antibodies and used to test the subcellular localisation for ZIP7 and ZnT7 without 
labeling to show nonspecific bounds. The nuclear DNA was stained with DAPI and all visual 
13 
Page 14 of 40Diabetes
images are presented for both S(E)R and Golgi testings in the four panels (Supplementary Fig. 
2). 
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As a more direct assay, the localization of ZIP7 and ZnT7 on the S(E)R was further 
investigated by Western (immuno4) blot analysis of isolated S(E)R fractions (ranging from 1 
to 14 in Figure 4B) obtained from rat heart homogenates. Immuno4blotting detected both 
ZIP7 and ZnT7 in all four fractions of S(E)R (Fig. 2E). The intensities of the immuno4 
cytochemical signal gradually increased moving from rough to smooth on the S(E)R for both 
transporters in these heart preparations. For validation of their presence in the S(E)R fractions, 
we also assessed SERCA2a levels in the same preparations, since this Ca
2+
ATPase is located 
to the S(E)R membrane in mammalian cardiomyocytes  (Figure 4B). As a negative control, 
we used a Golgi marker (Golgi458K) in isolated S(E)R fractions. As can be seen from the 
same figure, we did not observe any protein band in this examination.  
The above results confirm observations from the immunofluorescence examinations of 
localizations of ZIP7 and ZnT7 couple in the S(E)R of the rat heart. 
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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Based on measurements of Zn
2+
 release during the cardiac cycle we have previously proposed 
a role for intracellular free Zn
2+
 in cardiomyocytesand implicated the S(E)R as an intracellular 
Zn
2+
 pool(4). In a later study, we demonstrated that the eCALWY family of genetically4 
encoded FRET Zn
2+
 probes (Cyt4eCALWY4 and ER4eCALWY6 for cytosol and S(E)R, 
respectively)(13; 39) permitted the measurements of free Zn
2+ 
level in the S(E)R (5.6 ± 1.1 
nM) and cytosol (0.61 ± 0.07 nM) in isolated rat ventricular cardiomyocytes, separately(13).  
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Here, using the same Zn
2+
 probes, we measured the free Zn
2+ 
levels in the cytosol and S(E)R 
in H9c2 cells after culture at normal (5.5 mM) or high (25 mM) glucose for 24 hours. 
Representative free Zn
2+ 
measurement protocols using the FRET probes in H9c2 cells and the 
Zn
2+
–chelator TPEN (50 µM) followed by the  ionophore pyrithione (Pyr; 5 µM) plus ZnCl2 
(100 µM) are given in Fig. 3 (A for cytosol and B for S(E)R). Representative images, and the 
protocols for calibration, are given on the left and middle parts of the figures. By using 
quantification from fluorescence intensity4free Zn
2+ 
concentration approach(13), we observed 
that exposure of Cyt4eCALWY44infected H9c2 to high glucose (25 mM for 24 hours) induced 
significant increases in cytosolic free Zn
2+ 
levels compared to cells cultiured at low glucose 
(5.5 mM;  from 0.97 ± 0.14 nM to 1.74 ± 0.15 nM, =27 and 31 cells; p<0.05,  8 independent 
experiments; right panels in Figure 1A and Figure 1B). However, we detected significantly 
lower free Zn
2+ 
concentrations in high glucose4treated and ER4eCALWY6 infected H9c2 cells 
compared to the controls (from 4.88 ± 1.00 nM to 2.52 ± 0.36 nM, =22 and 26 cells p<0.05, 
8 independent experiments). 
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The demonstration of ZIP7 and ZnT7 localization to the S(E)R in H9c2 cells provided further 
evidence of a role for S(E)R as an intracellular Zn
2+ 
pool in cardiomyocytes(4). Furthermore, 
taken into consideration the relatively high mRNA and protein levels of ZIP7 together with its 
significantly higher phosphorylation level under hyperglycemic conditions, we wanted to 
assess its direct role in the redistribution of cellular free Zn
2+
 in hyperglycemic cells. We 
therefore silenced ZIP7 in H9c2 cells. The mRNA expression levels of ZIP7 and ZnT7 in 
these cells comparison to those of sc4shRNA cells are given in Fig. 4A and B (left, 
respectively). ZIP7 mRNA level in these cells was reduced by >60% in comparison to control 
cells while levels of ZnT7 mRNA were not changed. As expected, ZIP7 immunoreactivity 
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was reduced by >90 % in silenced cells while there was no change in ZnT7 protein levels 
(Fig. 4A and B, right, respectively). 
To further test the role of ZIP7 in controlling the subcellular distribution of Zn
2+
, we 
measured both cytosolic and S(E)R free Zn
2+ 
levels in non4targeted shRNA4infected H9c2 
cells using the genetically4encoded FRET4based Zn
2+
 probes Cyt4eCALWY4 or ER4 
eCALWY6, as described previously in sub4part 2 of the Results section. We analyzed cells 
maintained under physiological or hyperglycemic (25 mM glucose for 24 hours) conditions. 
As shown in Fig. 4C (left), cytosolic free Zn
2+ 
was increased over 34fold in hyperglycemic 
cells in comparison to the controls (from 0.92 ± 0.14 nM to 3.28 ± 0.65 nM; =36445, from 3 
independent experiments). Furthermore, the cytosolic free Zn
2+ 
level in ZIP74silenced cells 
under hyperglycemia was not different from that of ZIP7 silenced cells under physiological 
conditions (Fig. 4C, right). However, the S(E)R free Zn
2+ 
level in non4targeted shRNA 
infected cells expressing ER4eCALWY6 under hyperglycemia tended to decrease by about 
36% (from 2.86 ± 0.48 nM to 1.82 ± 0.42; =8412, from 3 independent experiments; Fig. 4D, 
left). Furthermore, the free Zn
2+ 
level in the S(E)R in ZIP74silenced cells under 
hyperglycemia was not different from that of ZIP7 silenced cells under physiological 
conditions (Fig. 4D, right). These results are consistent with an important role for S(E)R4 
localized ZIP7 in the re4distribution of subcellular Zn
2+ 
in cardiomyocytes under these 
pathological conditions.  
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Previously, we showed the presence of marked ER4stress and increased and increased 
intracellular free Zn
2+ 
in freshly isolated left ventricular cardiomyocytes from diabetic rats(5; 
34; 36). Importantly, these changes could be reversed by antioxidant treatment of the diabetic 
rats, significantly (5; 34; 36). 
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Of note, it has been demonstrated that Zn
2+ 
deficiency in the ER disrupts organelle function 
and induces ER4stress in eukaryotes (17). We therefore hypothesized that similar changes in 
cardiomyocytes might also lead to ER4stress under hyperglycemic conditions. To test this 
prediction, we first measured the levels of two molecular chaperones involved in ER4stress, 
namely GRP78 and Calregulin (CALR) in high glucose (25 mM  5.5 mM for 24 hours) 
incubated H9c2 cells in comparison to those of non4incubated controls.  As shown in Fig.  5A 
(left and right), the protein levels of GRP78 and CALR were increased significantly in 
hyperglycemia4exposed cells, which are similar to those of previously observed data in 
diabetic rat heart (40).  
In a further set of experiments we examined GRP78 induction in response to a direct ER4 
stress activator tunicamycin (TUN; 10 RM; 18 hours incubation). As shown in Fig. 5B, the 
GRP78 expression level was increased in TUN4incubated H9c2 cells. This finding can also 
support our previous data related with ER4stress chaperones GRP78 and CALR.  
To demonstrate a hypothesis related with hyperglycemia4associated changes in protein 
expression levels of ZIP7 and ZnT7 can underlie the induction of ER4stress in 
cardiomyocytes, we used directly ER4stress induced cardiomyocytes with TUN4incubation 
and then measured the protein levels of these Zn
2+
4transporters ZIP7 and ZnT7. As can be 
seen from Fig. 5C and D, the protein expression levels of both ZIP7 and ZnT7 measured in 
TUN4incubated cells were not different from those of controls, significantly. These last 
findings are also giving more support to our hypothesis of hyperglycemia associated changes 
in the protein expression levels of ZIP7 and ZnT7. 
 *	 8		
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Since we observed a markedly high phosphorylation level of ZIP7 in both chronic diabetic rat 
cardiaomyocytes (Fig. 1E) and high glucose incubated H9c2 cells as a time4dependent manner 
(Fig. 1F and G), we tested whether these changes may be a direct consequence of ER4stress. 
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We treated the H9c2 cells with 10 RM TUN to directly induce ER4stress and then measured 
phospho4ZIP7 levels. As can be seen in Fig. 5E, there were no significant differences between 
treated and untreated cells, implying no direct ER4stress effect on ZIP7 phosphorylation. 
(	 .   %  *) 	 
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Since the protein kinase CK2 activation has recently been shown to prompt cytosolic Zn
2+ 
signaling in a time4dependent manner(21), we examined the expression of CK2, firstly in 
isolated cardiomyocytes from left ventricle of diabetic rat heart. We also repeated the same 
measurements in Zn
2+
/Pyr (1 µM; 20 minutes)4incubated the rat cardiomyocytes comparison 
to those of controls. As shown in Fig. 6A, CK2 immunoreactivity in both samples was 
significantly high comparison to the controls. Furthermore, we repeated the above 
measurements in cells maintained at either high glucose4 (25 mM for 24 hours or 48 hours) or 
Zn
2+
/Pyr4 (1 µM for 20 minutes or 24 hours) incubated H9c2 cells. As can be seen from  Fig. 
6B,  high glucose incubation of H9c2 cells for 24 hours induced significant CK2 activation 
(over 24fold), in a time4dependent manner, because when the cells incubated with the same 
concentration of glucose for 48 hours, the activation was about 3.44fold, which is significantly 
higher than that of 24 hours (data not given).  Furthermore, when the H9c2 cells were 
incubated with 1 µM Zn
2+
/Pyr for 20 minutes, the CK2 activation level was measured as over
84fold high comparison to the control, however this activation was about 28% in 24 hours 
incubated H9c2 cells comparison to the control (data not given). These data demonstrate that 
CK2 expression is increased by hyperglycemia or elevated cytosolic free Zn
2+
, and may 
contribute in a feed4forward cycle to further Zn
2+
 release into the cytoplasm. Most 
importantly, it should be emphasized that elevated cytosolic free Zn
2+
 effect on CK2 
activation is time dependent and mostly developed in minutes rather than the hours. 
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As recently reported(21) a CK2 activation4dependent ZIP7 phosphorylation and Zn
2+
 influx 
into the cytoplasm occurs from the ER in TamR cells. We therefore performed co4 
immunoprecipitation experiment in H9c2 cells by using a ZIP74antibody and probed the 
precipitates for CK2 given their co4immunoprecipitation (Fig. 6C). These data, as shown 
previously as well, may reveal an association between CK2 activation and increased cytosolic 
free Zn
2+
4dependent phosphorylation and activation of ZIP7 in response to hyperglycemia.
In order to test whether ZIP7 can be phosphorylated with other endogenous  kinases, such as 
protein kinase A (PKA),  protein kinase C (PKC) and calcium4calmodulin kinase II 
(CaMKII), which play important roles for the phosphorylation of several proteins in different 
endogenous signaling pathways and themselves also are phosphorylated with hyperglycemia 
as well as with increased intracellular free Zn
2+ 
in cardiomyocytes (5; 36; 41), we performed 
co4immunoprecipitation experiment in H9c2 cells by using a ZIP74antibody and probed the 
precipitates for every kinases to obtain their co4immunoprecipitation. Unfortunately, we could 
not obtain any co4immunoprecipitation for ZIP7 either with PKA, PKC, or CaMKII. 
*	 
The overall aim of this study was to examine the roles of the Zn
2+ 
carriers ZIP7 and ZnT7 in 
cardiomyocytes under physiological conditions and as potential mediators of ER4stress in 
hyperglycemia and hyperglycemia4induced cardiac dysfunction. Our results suggest that ZIP7 
and ZnT7 are likely to carry Zn
2+
 in opposite directions across the S(E)R membrane. 
Furthermore, we showed that increased ZIP7 levels were likely to drive changes in the S(E)R 
lumen and in the cytosol, with deleterious consequences for cell function in  both cases. 
Although not assessed directly, lowered ZnT7 expression under conditions of hyperglycemia 
were likely to further exacerbate these changes and contribute to the deleterious consequences 
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of Zn
2+
 redistribution between compartments. Importantly, these two transporters were shown 
using both imaging and biochemical approaches to localize to the S(E)R membrane and may 
thus operate as a functional couple catalyzing Zn
2+
 release and uptake respectively from the 
S(E)R.  
To the best of our knowledge, the current study is the first to be conducted to assess both the 
localization and the functional roles of ZIP7 and ZnT7 as working opposing direction in the 
mammalian heart and, most importantly, their contributions to diabetic cardiac dysfunction 
via ER4stress. Additionally, we demonstrate increased levels of CK2 expression under 
hyperglycemic conditions and provide evidence that this may lead to phosphorylation of the 
channel on residues previously implicated in the control of Zn
2+
 release (21). Thus, a 
combination of transcriptional and post4transcriptional mechanisms may contribute to ZIP7 
activation in hyperglycemia and diabetes.  
Our present findings also provide further evidence of a role for the S(E)R as an intracellular 
Zn
2+
 pool, contributing to Zn
2+
 regulation in cardiomyocytes, in a process controlled by ZIP7 
and ZnT7.   In this regard, it has shown how ER Zn
2+ 
deficiency induces the unfolded protein 
response, UPR (17) and Zn
2+
 homeostasis is involved in UPR under stress conditions, via a 
putative Zn
2+
 transporter, localized to the ER(38). Moreover, and supporting the above 
findings, it has been demonstrated that high glucose is able to induce a stable increase in the 
cytosolic Zn
2+
 concentration in pancreatic β4cells and leads to profound alterations in the 
expression of genes important for Zn
2+
 homeostasis such as an increase in ZIP7 (2.44fold) and 
ZIP8 (6.84fold)(28). Therefore, our present observations are noteworthy when considering the 
important roles of ZIP7 and ZnT7 located to the S(E)R and responsible for ER4stress, in part, 
due to depressed S(E)R free Zn
2+
.
It has been demonstrated that either a direct cytosolic free Zn
2+
 increase or under
hyperglycemia in cardiomyocytes, similar to increased oxidative stress, could induce 
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markedly high phosphorylation in many endogenous kinases and oxidation of several proteins 
responsible for both electrical and mechanical activities of the heart (4; 5; 36; 42). This 
statement is consistent with recent studies on the role of ZIP7 in the control of Zn
2+
 release 
from S(E)R, resulting in the activation of multiple tyrosine kinases through Zn
2+
4mediated 
inactivation of protein phosphatases in cancer cells (20; 21). Supporting these earlier findings, 
we show here that the protein kinase CK2 is activated in hyperglycemia4exposed 
cardiomyocytes, while it can be also activated directly with increased cytosolic free Zn
2+
.
There are very little data to show the relation between intracellular free Zn
2+
, Zn
2+
4 
transporters and cardiovascular complications. In early studies, it has been demonstrated that 
Zn
2+ 
transporter, ZIP7, is involved in the Zn
2+ 
homeostasis of the Golgi apparatus (18). 
Although early studies have shown relatively weakly expressed ZIP7 and ZnT7 in 
mammalian heart tissue (25; 26), however, in here, we observed very strong protein 
expression levels of both ZIP7 and ZnT7 in diabetic rat heart tissue. Additionally, in previous 
studies, not in heart cells but in pancreatic beta cells, it is proposed that ZIP7 locates in the ER 
and to be involved in the release of Zn
2+ 
from intracellular stores (20; 28).
Other studies have also demonstrated a correlation between increased reactive oxygen species 
(ROS), ER4stress and the CK2 activation in a human cell line (43; 44). Zn
2+
 distribution has 
previously proposed top be controlled via the CK24mediated phosphorylation of ZIP7 (21). 
Furthermore, a protective role for ZnT7 against oxidative stress has also been proposed in 
mouse osteoblasts (45). Moreover, a high susceptibility to diet4induced glucose intolerance 
and insulin resistance has been demonstrated inZnT74null mice (27).  The present studies 
represent the first investigation into the role of CK24mediated phosphorylation of ZIP7 
activity and its role in zinc homeostasis in the cardiac myocyte. 
As discussed previously, hyperglycemia induces cardiac dysfunction due to increased 
oxidative stress and ER4stress (35; 37; 46). Our new data reinforce the prediction of a role for 
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S(E)R as an important Zn
2+ 
pool in these cardiomyocytes, with ZIP7 and ZnT7 both localized 
to this organelle and making an important contribution to  Zn
2+ 
homeostasis. Nonetheless, we 
recognize that other Zn
2+
4transporters (or Zn
2+ 
binding proteins)
 
may also contribute to the 
development of ER4stress in cardiomyocytes under pathological conditions. In this regard, 
mutations in the human 	
 gene cause the spondylocheiro dysplastic form of Ehlers–
Danlos syndrome, a heritable connective tissue disorder the result of vesicular Zn
2+
 trapping 
and ER Zn
2+ 
deficiency rather than overload has been shown recently(47). Recent studies also 
provided compelling evidence that mutations inactivating one copy of ZnT8/reduce 
Type 2 diabetes risk in humans, and suggest that ZnT8 inhibition may be a novel therapeutic 
strategy in Type 2 diabetes prevention (15). 
The present data provide important information related to Zn
2+
 homeostasis via a ZIP7 and 
ZnT7 functioning as opposing Zn
2+
4transporters and localized to S(E)R 
in cardiomyocytes. This appears to function to maintain proper S(E)R function. Perturbed 
expression of either or both transporters may lead to altered Zn
2+
 distribution across the S(E)R 
membrane, leading to persistent ER stress, and possibly to other sequelae including apoptosis. 
Fig. 7 presents our hypothesis due to a summary of these present findings. Additionally, other 
contributors, including increased oxidative stress under hyperglycemia (this possibility has 
been discussed previously in a review article (48) may increase cytosolic free Zn
2+
 as a result 
of Zn
2+
 mobilization from metalloproteins (49). The latter might further stimulate ZIP7 
activity and in turn, may lead to accelerated Zn
2+ 
influx into the cytosol from the S(E)R.
As conclusion, in this study, we provided novel insights into the regulation of Zn
2+ 
homeostasis in the heart and its role in hyperglycemia and diabetes4associated heart 
dysfunction. These findings may provide new targets, such as regulation of cellular Zn
2+
, 
mediation of Zn
2+
4transporters in this regulation, and protein kinase CK2 as endogenous 
target kinase against diabetes4induced cardiac dysfunction.  
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	5		:ThemRNA and protein levels 
of ZIP7 (A) and ZnT7 (B) in ventricular cardiomyocytes isolated from either diabetic (DM) or 
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control (CON) rats (see Methods). The mRNA expression and protein levels of ZIP7 (C) and 
ZnT7 (D) from high glucose incubated (25 mM  5.5 mM for 24 hours) H9c2 cells. 
Densitometric analysis showing (upper part of the bars) ZIP7 and ZnT7 are expressed at ∼50 
kDa and 42 kDa, respectively. The ZIP7 phosphorylation in cardiomyocytes under chronic 
hyperglycemia (diabetic rat cardiomyocytes; DM group) comparison to the controls (CON) 
(E), and H9c2 cells incubated with high glucose, HG (25 mM for 24 or 48 hours) (F; left and 
right). The phosphorylation levels of ZIP7 are measured by using phospho4ZIP7 antibody 
developed by KT Lab and given with comparison to their controls.  Bars represent mean 
(±SEM). Number of samples, =5–6 for hearts/group/protocol and measurements with double 
assays in each sample from each group for each type of measurement. Significance level 
accepted at *p<0.05  CON. 
,::<3 	3   	"#
	 	

5	 	: Localizations of either ZIP7 (A) or ZnT7 (B) to either the S(E)R or Golgi 
apparatus (C and D, respectively) were visualized by using confocal micrographs in H9c2 
cells. To examine the subcellular localizations of ZIP7 or ZnT7 to S(E)R, H9c2 cells were 
transfected with ER4resident Discosoma red fluorescent protein (DsRed4 ER) to label ER or 
incubated with GM130 antibody to label Golgi apparatus. All cells were fixed and 
permeabilized (see Research Design and Methods). DsRed4ER transfected cells incubated 
with specific either ZIP7 or ZnT7 primary antibodies and followed by secondary antibodies 
(Alexa Fluor 488 Donkey anti4Rabbit IgG or  Alexa Fluor 488 Donkey anti4Goat IgG, 
respectively). To test their possible Golgi localizations (C and D), the non4transfected cells 
were incubated with either ZIP7 or ZnT7 primary antibodies and GM130 primary antibody, 
and then followed by secondary antibodies (Alexa Fluor 488 Donkey anti4Rabbit IgG and 
Alexa Fluor 568 Goat anti4Mouse IgG  or Alexa Fluor 488 Donkey anti4Goat IgG and Alexa 
Fluor 568 Rabbit anti4Mouse IgG, respectively). The cells were mounted medium containing 
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DAPI (blue; to stain nuclei). Single optical sections (upper panels) and representative z4plane 
reconstructions (side and lower panels) are shown. The insets in right hand side panels show a 
magnified region. Bar, 104Rm. For colocalization values, the Pearson coefficients calculated 
for ZIP7 and S(E)R as well as ZnT7 and S(E)R by using the Huggens programme (see 
Materials and Methods), were 0.67± 0.07 and 0.72±0.13, respectively. (E) Either ZIP7 or 
ZnT7 individual localization to the S(E)R was investigated with Western (immuno)4blot 
analysis in isolated S(E)R fractions (fractions from 1 to 14). Immunoblotting detected either 
ZIP7 or ZnT7 in all four fractions containing S(E)R membranes. For validation of S(E)R 
localization of ZIP7 and ZnT7, 58K Golgi Protein (Abcam, ab427043) was used as Golgi 
marker. 
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	5		(-12):Representative traces (upper part) and 
ratiometric images (lower) are shown for H9c2 cells expressing cytosolic (A) or ER4targeted 
(B) sensors. Acquisitions were performed 24 hours after transfection or infection and during 
perfusion with Krebs4HEPES4bicarbonate (KHB) buffer. Steady state fluorescence intensity 
ratio (citrine/cerulean) was first measured before the maximum ratio was obtained under 
perfusion with KHB buffer containing 50 RM TPEN. Finally, the minimum ratio was obtained 
under perfusion with KHB buffer containing 5 RM Zn
2+
4pyrithione (Zn
2+
/Pyr) and 100 RM 
ZnCl2 (Zn
2+
4saturated condition). Cells were incubated with high glucose (HG; 25 mM for 24 
hours) and the cytosolic and ER free Zn
2+
 levels are given comparison to the controls (CON). 
Bars represent mean (±SEM) and >20 cells in every protocol. Significance level accepted at 
*p<0.05  CON.
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	 :TheZIP7 silencing was confirmed by measuring ZIP7 and ZnT7 mRNA (A) and 
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protein (B) levels with respect to scrambled shRNA4infected cells. ZIP7 silencing does not 
affect ZnT7 mRNA (A; right) or protein (B; right) levels. The cytosolic (C) and S(E)R (D) 
free Zn
2+
 levels measured in ZIP7 silenced H9c2 cells under hyperglycemic conditions using 
expressed eCALWY sensors (FRET measurements were carried out as for Fig. 3) and 
comparison to those in scrambled shRNA4treated cells. Bars represent mean (±SEM) and 
=8436 cells for each protocol. Significance level accepted at *p<0.05  scramble4cells. 
,:?:	 	
  5		. To test whether 
hyperglycemia induces changes in the protein levels of ZIP7 and ZnT7 and then turns to 
further underlie the induction of ER4stress in H9c2 cells, two molecular chaperones, GRP78 
(A, left) and calregulin (CALR; A, right) are measured by Western (immuno4) blotting, in 
H9c2 cells incubated with either high glucose (HG; 25 mM, 24 hours). (B) GRP78 measured 
under directly ER4stress induction with tunicamycin (TUN). Protein levels of ZIP7 (C) and 
ZnT7 (D) were measured after ER4stress induction with TUN. (E) Phospho4ZIP7 protein level 
was measured in H9c2 cells incubated with TUN with respect to GAPDH as reference 
protein. Bars represent mean (±SEM) and data were obtained after duplicate assays of each 
sample from each group for each type of measurement. Significance level accepted at *p<0.05 
 CON. 
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: @:(	 .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    		3   %  : (A) The 
protein level of protein kinase CK2 measured at 43 kDa in cardiomyocytes from normal 
(CON) and diabetic (DM) rats, and isolated cardiomyocytes incubated with an ionophore 
Zn
2+
4pyrithione (Zn
2+
/Pyr; 1 µM for 20 minutes). (B) H9c2 cells incubated either with high 
glucose (HG; 25 mM for 24 hours) or Zn
2+
/Pyr (1 µM for 20 minutes). (C) To determine 
whether ZIP7 phosphorylation is associated with CK2 activation or   in 
hyperglycemia4exposed cells, co4immunoprecipitation experiments were performed using 
29 
anti4ZIP7 antibody and probed the precipitates for CK2 in H9c2 cells. The bars are given as 
mean (±SEM) and data obtained with double assays in each sample from each group for each 
type of measurement. Significance level accepted at *p<0.05  CON. 
,: : !	
 	         

 
   	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	 
		
		 : (A) Regulation of cellular distribution 
of free Zn
2+
 via a ZIP7 and ZnT7 system localized to the sarco(endo)plasmic reticulum
[S(E)R] in resting cardiomyocytes. (B) Hyperglycemia can stimulate an increase of cytosolic 
free Zn
2+ 
in cardiomyocytes as a result of the mobilization of Zn
2+
 from metalloproteins. This
increase can induce either directly ER4stress via inducing overexpression of ER4stress 
chaperons or up4regulation of CK2, which, in turn, leads to activation of CK2 inducing Zn
2+
influx into the cytosol from the S(E)R.  Phosphorylation of ZIP7(21) and downregulation of 
ZnT7 may further contribute to these changes.  
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Online Supplementary Tables 
Supplementary Table 1. Effect of ZIP7shRNA constructs upon ZIP7expression in the 
cells.
Supplementary Table 2. Sequences of primers used for qRTPCR. 
Sense (5`−3`) Antisense (5`−3`)
ZIP7  
ZnT7  
βactin  
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Supplementary Fig. 1:The mRNA expression levels of ZIP7 and ZnT7 in isolated cardiomyocytes from left 
ventricle of normal rat heart incubated with high glucose.  Freshly isolated rat left ventricular cardiomyocytes 
incubated with high glucose (33 mM) for 3 hours (+HG group) and then examined the protein and mRNA levels of 
both ZIP7 and ZnT7 comparison to those of mannitol (23 mM) incubated cardiomyocytes (CON group). Bars 
represent mean (±SEM). Number of cells used are isolated from n=3–4 hearts/group and measurements performed 
with double assays in each sample from each group for each type of measurement. Significance level accepted at 
*p<0.05 vs CON.
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Supplementary Fig. 2. Negative controls of ZIP7, ZnT7 and GM130 in H9c2 cells. dsRED-ER(red) transfected cells 
were fixed and permeabilized with 4% paraformaldehyde and 0.2% Triton-X100, respectively. Cells were incubated 
only with secondary antibodies for ZIP7 and ZnT7 negative controls (Alexa Fluor 488 Donkey anti-Rabbit; 1:1000 and 
Alexa Fluor 488 Donkey anti-Goat; 1:1000, respectively) (A and B).  Cells after fixation and permeabilization are 
incubated only with secondary antibodies for ZIP7 and GM130 negative controls (Alexa Fluor 488 Donkey anti-
Rabbit; 1:1000 and Alexa Fluor 568 Goat anti-Mouse; 1:1000, respectively),  secondary antibodies for ZnT7 and 
GM130 negative controls (Alexa Fluor 488 Donkey anti-GFor Peer Review Onlyoat; 1:1000 and Alexa Fluor 647 Rabbit anti-Mouse; 1:1000, 
respectively) (C and D). They were mounted with mounting medium contains DAPI (blue). 
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